Canada markets close in 1 hour 4 minutes

Eterna Therapeutics Inc. (ERNA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.1612-0.0088 (-0.41%)
As of 11:09AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
68
68
0
0
0
Cost of Revenue
236
236
0
-
-
Gross Profit
-168
-168
0
-
-
Operating Expenses
Research Development
5,920
5,920
10,392
12,705
3,951
Selling General and Administrative
14,586
14,586
16,555
14,724
3,297
Total Operating Expenses
20,506
20,506
26,947
27,429
7,248
Operating Income or Loss
-20,674
-20,674
-26,947
-27,429
-7,248
Interest Expense
614
614
30
74
43
Total Other Income/Expenses Net
-521
-521
2,443
-94,978
-19,240
Income Before Tax
-21,671
-21,671
-24,534
-122,481
-7,291
Income Tax Expense
-3
-3
45
64
0
Income from Continuing Operations
-21,668
-21,668
-24,579
-122,545
-7,291
Net Income
-21,668
-21,668
-24,579
-122,545
-7,291
Net Income available to common shareholders
-21,684
-21,684
-24,595
-122,561
-7,291
Basic EPS
-3.96
-
-8.06
-56.61
-3.51
Diluted EPS
-3.96
-
-8.06
-56.61
-3.51
Basic Average Shares
4,871
-
3,051
2,165
2,076
Diluted Average Shares
5,410
-
3,051
2,165
2,076